One ARK Invest exchange-traded fund run by ETF star Cathie Wood sold over 230,000 shares of Pfizer Inc. (NYSE: PFE) on Tuesday, as the price of this fund pulled back over 2% in the day’s session. However, it is up a fair amount in the past year.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) parted with 238,235 shares of Pfizer. At Tuesday’s closing price, this would have valued this sale at roughly $11.3 million. This is only a small fraction of the total holdings. The fund is up about 10% over the past 52 weeks.
Check out all the ARK Invest buys for Tuesday:
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of 247wallst.com.